骨质疏松症的药物治疗新进展

被引:8
作者
曹丽梅
李波
机构
[1] 中国药品生物制品检定所国家药物安全评价中心
[2] 中国药品生物制品检定所国家药物安全评价中心 北京
[3] 北京
关键词
骨质疏松症; 降钙素; 骨形成促进剂; 骨吸收; 骨密度; 骨质密度; 药物治疗;
D O I
10.16153/j.1002-7777.2005.11.018
中图分类号
R58 [内分泌腺疾病及代谢病];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:42 / 45
页数:4
相关论文
共 23 条
[1]  
Interactions of PTH and PTHrP with the PTH/PTHrP receptor and with downstream signaling pathways: exceptions that provide the rules. D Goltzman. Journal of Bone and Mineral Research . 1999
[2]  
Increases in BMD afterdiscontinuation of daily human PTH and GHRHadministration in women with endometriosis. Finkelstein JS,Arnold AL. Journal of Clinical Endocrinology and Metabolism . 1998
[3]  
Impaired GHsecretion in the adults population:relation to age andadiposity. Rudman DV,Vintner MH,Rosers CM,et al. The Journal of Clinical Investigation . 1981
[4]  
Effect of humangrowth hormone in men over age 60. Rudman DV,Feller AG,Nagrog HS,et al. The New England Journal of Medicine . 1990
[5]  
A 10?year prospective study of primary hyperparathyroidism with or without parathyroid surgery. SJ Silverberg,E Shane,TP Jacobs,E Siris,JP Bilezikian. The New England Journal of Medicine . 1999
[6]  
A potent analog of1α,25-dihydroxyvitamin D3selectively induces bone formation. Shevde N K,Plum L A,Clagett Dame M,et al. Proceedings of the National Academy of Sciences of the United States of America . 2002
[7]  
Stimulation of bone formation in vitro and in rodents by statins. G Mundy,R Garrett,S Harris. Science . 1999
[8]  
Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. Jilka RL,Weinstein RS,Bellido T, et al. Clinical Investigator . 1999
[9]  
Parathyroid Hormone Causes Translocation of Protein Kinase C from Cytosol to Membranes in Rat Osteosarcoma Cells. A. B. Abou Samra,H. Juppner,D. Westerberg,J. T. Potts,G. V. Segre. The Journal of Endocrinology . 1989
[10]  
Anabolic effects of PTH on bone. Morley P,Whitfield JF,Willick GE,et al. Trends in Endocrinology and Metabolism . 1997